A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/23/1998	EP0885306A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
12/23/1998	EP0885301A1 Down-regulation resistant c3 convertase
12/23/1998	EP0885299A1 Wsx receptor and ligands
12/23/1998	EP0885297A1 Novel era
12/23/1998	EP0885294A2 Cardiotrophin and uses therefor
12/23/1998	EP0885293A1 Human chemokine polypeptides
12/23/1998	EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy
12/23/1998	EP0885243A1 Crystal structure of apopain and uses thereof
12/23/1998	EP0885242A1 Peptides and compounds that bind to a thrombopoietin receptor
12/23/1998	EP0885241A1 Purification method
12/23/1998	EP0885189A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
12/23/1998	EP0885186A1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
12/23/1998	EP0885046A1 Filtration of plasma mixtures using cellulose-based filter aids
12/23/1998	EP0885017A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours
12/23/1998	EP0885011A2 Vaccines
12/23/1998	EP0885010A1 Intercellular adhesion molecule powder formulation
12/23/1998	EP0885002A2 Materials and methods for enhancing cellular internalization
12/23/1998	EP0884950A1 A method of killing or inhibiting microbial cells
12/23/1998	EP0884947A1 Dna vaccination for induction of suppressive t cell response
12/23/1998	EP0884946A1 Intracellular vitamin d binding protein
12/23/1998	EP0728012A4 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
12/23/1998	EP0722459B1 Hemoregulatory penta- or hexapeptides
12/23/1998	EP0690675A4 Nucleic acid coding for a tumor rejection antigen precursor
12/23/1998	EP0663826B1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
12/23/1998	EP0652975A4 Assessment of trans-acting factors allelic variation.
12/23/1998	EP0648276B1 Monoclonal antibodies to glycoprotein p
12/23/1998	EP0594847B1 Dna coding for human fk506-binding protein and expression thereof
12/23/1998	EP0553294B1 The manufacture of compositions for the treatment of cell proliferation disorders
12/23/1998	EP0541629B1 Cloning and expression of a rhoptry associated protein of (p.falciparum)
12/23/1998	CN1202934A Delivery of biologically active polypeptides
12/23/1998	CN1202932A Therapeutic antiangiogenic compositions and methods
12/23/1998	CN1202931A Tumour vaccine and process for the preparation thereof
12/23/1998	CN1202907A Cyclopeptide derivatives
12/23/1998	CN1202906A Type CC chemokine-like protein
12/23/1998	CN1202904A Cyclopeptolides
12/23/1998	CN1202903A Targeted cytotoxic anthracycline analogs
12/23/1998	CN1202902A Thrombin inhibitors
12/23/1998	CN1202901A Phosphonic acid derivatives with metallopeptidase inhibitory activity
12/23/1998	CN1202900A Inhibition of tumor growth by antisense oligonucleotides for IL-8 and Il-8 receptor
12/23/1998	CN1202882A New LH-RH antigonists with improved effectiveness
12/23/1998	CN1202826A Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral scherosis
12/23/1998	CN1202824A Combinational therapeutic methods employing nitric oxide scavengers
12/23/1998	CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness
12/23/1998	CN1202821A Compositions and methods for buccal delivery of pharmaceutical agent
12/23/1998	CN1202820A Buccal delivery of glucagon-like insulinotropic peptides
12/23/1998	CN1202818A Solubilisation method
12/23/1998	CN1041281C Polymer-bound taxol derivatives
12/23/1998	CA2698626A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
12/23/1998	CA2295994A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998	CA2295928A1 Disease associated protein kinases
12/23/1998	CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998	CA2295207A1 Hammerhead ribozymes with extended cleavage rule
12/23/1998	CA2294585A1 An oral care composition comprising a bacillus pullulanase and a dextranase
12/23/1998	CA2294569A1 Secreted proteins and polynucleotides encoding them
12/23/1998	CA2294563A1 New human lysophospholipase
12/23/1998	CA2294519A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998	CA2294435A1 Human preprotachykinin b
12/23/1998	CA2294141A1 Treatment of diabetes with rosiglitazone and insulin
12/23/1998	CA2293998A1 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998	CA2293740A1 Apo-2dcr, a tnf-related receptor
12/23/1998	CA2293735A1 Lag-3 splice variants
12/23/1998	CA2293732A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
12/23/1998	CA2287540A1 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
12/22/1998	US5852188 Oligonucleotides having chiral phosphorus linkages
12/22/1998	US5852187 Molecular cloning of the ovine pituitary growth hormone releasing hormone receptor
12/22/1998	US5852186 Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof
12/22/1998	US5852182 Thiol-derivatized oligonucleosides
12/22/1998	US5852177 Basic fibroblast growth factor (bFGF) muteins
12/22/1998	US5852176 Antibodies to receptors for human interleukin-12
12/22/1998	US5852175 P-selectin glycoprotein ligand blocking antibodies
12/22/1998	US5852174 Antibodies to liver derived receptors for advanced glycosylation endproducts and uses therefor
12/22/1998	US5852173 TNF receptor death ligand proteins and inhibitors of ligand binding
12/22/1998	US5852171 Cloning and regulation of an endothelial cell protein C/activated protein C receptor
12/22/1998	US5852170 ICAM-4 materials and methods
12/22/1998	US5852169 Max-interacting proteins and related molecules and methods
12/22/1998	US5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
12/22/1998	US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998	US5852051 Dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals
12/22/1998	US5852033 Methods of treatment using lamellarin-class alkaloids
12/22/1998	US5852004 Drug and pharmaceutical composition for the treatment of lesions of the digestive tract
12/22/1998	US5852002 Treatment of conditions and disease
12/22/1998	US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998	US5851997 Use of human chorionic gonadotropin as an immune-potentiating antiviral agent
12/22/1998	US5851996 Materials and methods for treatment of plaquing diseases
12/22/1998	US5851995 Anti-obesity proteins
12/22/1998	US5851994 Compositions that inhibit wound contraction and methods of using same
12/22/1998	US5851993 Suppression of tumor cell growth by syndecan-1 ectodomain
12/22/1998	US5851992 Treatment of growth hormone deficiency
12/22/1998	US5851991 Therapeutic use of the retinoblastoma susceptibility gene product
12/22/1998	US5851990 bFGF mutein and its production
12/22/1998	US5851989 Method of extending the plasma half-life of vascular endothelial cell growth factor
12/22/1998	US5851987 Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides
12/22/1998	US5851986 Promoting bone formation and inhibiting bone resorption with high mobility group protein-1 (HMG-1)
12/22/1998	US5851985 Treatment of tumors by arginine deprivation
12/22/1998	US5851984 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
12/22/1998	US5851983 Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
12/22/1998	US5851839 Platelet aggregation inhibitors
12/22/1998	US5851832 In vitro growth and proliferation of multipotent neural stem cells and their progeny
12/22/1998	US5851828 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
12/22/1998	US5851824 Human calcium channel α-1C/α-1D, α-2, β-1, and γsubunits and cells expressing the DNA

1 ... 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 ... 3163